World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
31502
World Ranking
10108
National Ranking
556

Overview

Ken Herrmann is affiliated with the German Cancer Research Center in Germany. Their research spans primarily the field of Medicine, with a significant focus on subfields including Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Epidemiology, and Cancer Research.

Herrmann's major topics of work reflect this focus and include Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, Neuroendocrine Tumor Research Advances, Peptidase Inhibition and Analysis, and Prostate Cancer Diagnosis and Treatment.

Frequent publication venues where Herrmann has contributed numerous articles include:

  • Journal of Nuclear Medicine
  • European Journal of Nuclear Medicine and Molecular Imaging
  • Nuklearmedizin - NuclearMedicine
  • Journal of Clinical Oncology
  • Cancers

Notable recent papers by Herrmann feature significant topics in oncology and nuclear medicine such as:

  • Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer, 2021, New England Journal of Medicine
  • E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection, 2021, JAMA Oncology
  • Radiotheranostics in oncology: current challenges and emerging opportunities, 2022, Nature Reviews Clinical Oncology
  • PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0, 2023, European Journal of Nuclear Medicine and Molecular Imaging

Herrmann collaborates frequently with a network of scholars with whom they have multiple coauthored publications. Key collaborators include Wolfgang P. Fendler, Lale Umutlu, Christoph Rischpler, Boris Hadaschik, and Matthias Eiber.

Best Publications

  • Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

    Oliver Sartor;Johann de Bono;Kim N Chi;Karim Fizazi

  • PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

    Florian Lordick;Katja Ott;Bernd-Joachim Krause;Wolfgang A Weber

  • 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.

    Wolfgang P. Fendler;Wolfgang P. Fendler;Matthias Eiber;Matthias Eiber;Mohsen Beheshti;Jamshed Bomanji

  • Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial

    Wolfgang P Fendler;Wolfgang P Fendler;Jeremie Calais;Matthias Eiber;Matthias Eiber;Robert R Flavell

  • Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

    Katja Ott;Wolfgang A. Weber;Florian Lordick;Karen Becker

  • Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

    Matthias Eiber;Matthias Eiber;Ken Herrmann;Jeremie Calais;Boris Hadaschik

  • The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

    B. J. Krause;M. Souvatzoglou;M. Tuncel;K. Herrmann

  • Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches

    Andreas K. Buck;Ken Herrmann;Tom Stargardt;Tobias Dechow

  • EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).

    Clemens Kratochwil;Wolfgang Peter Fendler;Matthias Eiber;Richard Baum

  • 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning

    Jeremie Calais;Johannes Czernin;Minsong Cao;Amar U. Kishan

  • Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.

    Thomas A. Hope;Thomas A. Hope;Emily K. Bergsland;Murat Fani Bozkurt;Michael Graham

  • 2-[18F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical Prostatectomy

    Heiko Schöder;Ken Herrmann;Mithat Gönen;Hedvig Hricak

  • First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease

    Ken Herrmann;Margret Schottelius;Constantin Lapa;Theresa Osl

  • E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

    Francesco Ceci;Daniela E. Oprea-Lager;Louise Emmett;Judit A. Adam

  • PET/CT with 11 C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data

    Stefano Fanti;Silvia Minozzi;Paolo Castellucci;Sara Balduzzi

  • 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.

    Christina Bluemel;Markus Krebs;Bülent Polat;Fränze Linke

  • Prostate-Specific Membrane Antigen Ligand Positron-Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.

    Wolfgang P. Fendler;Manuel Weber;Amir Iravani;Michael S. Hofman

  • Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial

    Thomas A Hope;Thomas A Hope;Matthias Eiber;Matthias Eiber;Wesley Robert Armstrong;Roxanna Juarez

  • (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.

    Christian Meyer zum Büschenfelde;Ken Herrmann;Tibor Schuster;Hans Geinitz

  • Comparison of Integrin αvβ3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDG

    Ambros J. Beer;Sylvie Lorenzen;Stephan Metz;Ken Herrmann

Frequent Co-Authors

Johannes Czernin
Johannes Czernin University of California, Los Angeles
Markus Schwaiger
Markus Schwaiger Technical University of Munich
Gerald Antoch
Gerald Antoch Heinrich Heine University Düsseldorf
Hans-Jürgen Wester
Hans-Jürgen Wester Technical University of Munich
Michael Forsting
Michael Forsting University of Duisburg-Essen
Stefano Fanti
Stefano Fanti University of Bologna
Tibor Schuster
Tibor Schuster McGill University
Christian Peschel
Christian Peschel Technical University of Munich
Florian Lordick
Florian Lordick Leipzig University
Jürgen R. Reichenbach
Jürgen R. Reichenbach Friedrich Schiller University Jena

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA often opens doors to a variety of healthcare careers beyond becoming a physician. For those seeking practical entry points, some students consider programs like the easiest nursing schools to get into, which offer more accessible admission requirements and a faster pathway to working in patient care.

If you prefer administrative or technical roles, the best online medical billing and coding schools provide flexible learning so you can earn certification and begin your career in medical records management.

Some nursing programs support alternative admissions for motivated learners. For instance, you may find a nursing school without teas test requirements, reducing barriers for applicants and streamlining the enrollment process.

Interested in healthcare leadership? Consider earning an online healthcare management degree to qualify for management roles within hospitals, clinics, or public health organizations. These options give students a wide array of alternative pathways in the ever-growing healthcare sector.

Best Scientists Citing Ken Herrmann

Trending Scientists

Recently Published Articles